By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Join Professor John Camm for his discussion on Atrial Fibrillation.
BBC Breakfast News
Patients and network staff talk about their experiences of being involved in clinical research.
Atrial Fibrillation Antiarrhythmic Drugs.
Professor John Camm discusses the two newest antiarrhythmic drugs dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away.
Watch us work.
Now's your chance to watch us work - check out the video below for a snapshot of our bustling team in action.
Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence
September 1, 2025
Richmond Pharmacology is delighted to announce the promotion of Patrick Ramiah to the role of Director of Clinical Project Delivery & Operational Excellence, effective from 1 September 2025.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
.svg){kind=small}
.avif)
